DaVita
DVA
#1634
Rank
A$18.97 B
Marketcap
A$295.58
Share price
-0.37%
Change (1 day)
38.95%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$16.39

According to DaVita's latest financial reports the company's current EPS (TTM) is A$15.56. In 2025 the company made an earnings per share (EPS) of A$14.31 a decrease over its 2024 EPS that were of A$15.60.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$16.3914.54%
2025A$14.31-8.25%
2024A$15.6044.94%
2023A$10.7627.26%
2022A$8.46-35.56%
2021A$13.1344.1%
2020A$9.1119.7%
2019A$7.61540.48%
2018A$1.19-76.07%
2017A$4.96-19.31%
2016A$6.15242.52%
2015A$1.80-62.87%
2014A$4.8413.43%
2013A$4.268.45%
2012A$3.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$34.38 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$16.07 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$27.51 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.73-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA